We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Acadia Healthcare (ACHC) Q4 Earnings Top Mark, Improve Y/Y
Read MoreHide Full Article
Acadia Healthcare Company, Inc. (ACHC - Free Report) reported fourth-quarter 2019 adjusted earnings of 51 cents per share, beating the Zacks Consensus Estimate by 4.1% and also improving 8.5% year over year.
The company’s impressive results reflect higher revenues, driven by segmental contributions, lower expenses and rise in patient days.
Acadia Healthcare Company, Inc. Price, Consensus and EPS Surprise
Revenues of Acadia Healthcare rose 4.9% year over year to $780.2 million but missed the Zacks Consensus Estimate by 0.6% year over year.
Total same facility revenues grew 4.5% with 0.4% increase in patient days and 4.1% rise in revenues per patient day.
U.S. same facility revenues were up 5.5% year over year to $488.1 million. The segment also recorded 2.4% year-over-year increase in patient days and 3% growth in revenue per patient day.
U.K. same facility revenues rose 2.7% year over year to $254.3 million. The number of patient days declined 2% from the year-earlier period whereas revenues per patient per day were up 4.7%.
Acadia Healthcare’s consolidated adjusted EBITDA for the fourth quarter of 2019 was $144.4 million compared with $133.9 million for the fourth quarter of 2018.
Consolidated EBITDA margin on same facility basis was 22%, expanding 20 basis points year over year.
Total expenses decreased 27.1% year over year to $790.5 million on the back of null legal settlements expenses, lower loss on impairment, lower transaction-related expenses.
In the reported quarter, the company added 171 beds in total to its operations, of which 150 beds are in the U.S. operations while 21 belong to the U.K. operations.
Financial Update
Cash and cash equivalents as of Dec 31, 2019 were $124.2 million, soaring 145.9% from the level at 2018 end.
Long-term debt was $3.1 billion as of Dec 31, 2019, down 1.7% from the figure as of Dec 31, 2018.
Net cash provided by operating activities for the year was $332.9 million, down 20.1% year over year.
The company exited 2019 with total assets worth $6.8 billion, up 11.4% year over year.
2020 Guidance
For 2020, the company expects adjusted earnings per share between $2.20 and $2.40 on revenues of $3.28-$3.34 billion.
Adjusted EBITDA is anticipated between $610 million and $630 million.
The company expects to add around 600 beds in the United States in 2020.
Depreciation and amortization expense is anticipated in the range of $175-$180 million while interest expense is expected within $172-$177 million. Total capital expenditure for the year is expected between $330 million and $350 million.
Q1 Guidance
Acadia Healthcare also provided guidance for the first quarter of 2020 wherein it expects revenues between $795 million and $805 million. Adjusted EBITDA for the quarter is anticipated between $133 million and $137 million. Meanwhile, adjusted earnings per share are projected in the band of 37-42 cents.
Full-Year Highlights
For the full year, the company posted adjusted earnings of $2.04 per share, down 8.9% year over year. In 2019, the company added a total of 585 hospitals to its current and new facilities.
For 2019, total revenues of $3.1 billion were up 3.2% year over year.
Among other medical sector players that already reported fourth-quarter earnings, the bottom-line results of UnitedHealth Group Incorporated (UNH - Free Report) and HCA Healthcare, Inc. (HCA - Free Report) beat estimates while Anthem Inc.’s earnings missed the consensus mark.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Image: Bigstock
Acadia Healthcare (ACHC) Q4 Earnings Top Mark, Improve Y/Y
Acadia Healthcare Company, Inc. (ACHC - Free Report) reported fourth-quarter 2019 adjusted earnings of 51 cents per share, beating the Zacks Consensus Estimate by 4.1% and also improving 8.5% year over year.
The company’s impressive results reflect higher revenues, driven by segmental contributions, lower expenses and rise in patient days.
Acadia Healthcare Company, Inc. Price, Consensus and EPS Surprise
Acadia Healthcare Company, Inc. price-consensus-eps-surprise-chart | Acadia Healthcare Company, Inc. Quote
Quarterly Details
Revenues of Acadia Healthcare rose 4.9% year over year to $780.2 million but missed the Zacks Consensus Estimate by 0.6% year over year.
Total same facility revenues grew 4.5% with 0.4% increase in patient days and 4.1% rise in revenues per patient day.
U.S. same facility revenues were up 5.5% year over year to $488.1 million. The segment also recorded 2.4% year-over-year increase in patient days and 3% growth in revenue per patient day.
U.K. same facility revenues rose 2.7% year over year to $254.3 million. The number of patient days declined 2% from the year-earlier period whereas revenues per patient per day were up 4.7%.
Acadia Healthcare’s consolidated adjusted EBITDA for the fourth quarter of 2019 was $144.4 million compared with $133.9 million for the fourth quarter of 2018.
Consolidated EBITDA margin on same facility basis was 22%, expanding 20 basis points year over year.
Total expenses decreased 27.1% year over year to $790.5 million on the back of null legal settlements expenses, lower loss on impairment, lower transaction-related expenses.
In the reported quarter, the company added 171 beds in total to its operations, of which 150 beds are in the U.S. operations while 21 belong to the U.K. operations.
Financial Update
Cash and cash equivalents as of Dec 31, 2019 were $124.2 million, soaring 145.9% from the level at 2018 end.
Long-term debt was $3.1 billion as of Dec 31, 2019, down 1.7% from the figure as of Dec 31, 2018.
Net cash provided by operating activities for the year was $332.9 million, down 20.1% year over year.
The company exited 2019 with total assets worth $6.8 billion, up 11.4% year over year.
2020 Guidance
For 2020, the company expects adjusted earnings per share between $2.20 and $2.40 on revenues of $3.28-$3.34 billion.
Adjusted EBITDA is anticipated between $610 million and $630 million.
The company expects to add around 600 beds in the United States in 2020.
Depreciation and amortization expense is anticipated in the range of $175-$180 million while interest expense is expected within $172-$177 million. Total capital expenditure for the year is expected between $330 million and $350 million.
Q1 Guidance
Acadia Healthcare also provided guidance for the first quarter of 2020 wherein it expects revenues between $795 million and $805 million. Adjusted EBITDA for the quarter is anticipated between $133 million and $137 million. Meanwhile, adjusted earnings per share are projected in the band of 37-42 cents.
Full-Year Highlights
For the full year, the company posted adjusted earnings of $2.04 per share, down 8.9% year over year. In 2019, the company added a total of 585 hospitals to its current and new facilities.
For 2019, total revenues of $3.1 billion were up 3.2% year over year.
Zacks Rank and Performance of Other Players
Acadia Healthcare currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Among other medical sector players that already reported fourth-quarter earnings, the bottom-line results of UnitedHealth Group Incorporated (UNH - Free Report) and HCA Healthcare, Inc. (HCA - Free Report) beat estimates while Anthem Inc.’s earnings missed the consensus mark.
5 Stocks Set to Double
Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>